| # | Drug | Count |
|---|---|---|
| 0 | BUROSUMAB | 10 |
| 1 | DENOSUMAB | 9 |
| 2 | ZOLEDRONIC ACID | 9 |
| 3 | ADALIMUMAB | 5 |
| 4 | FERRIC CARBOXYMALTOSE | 5 |
| 5 | FERRIC CARBOXYMALTOSE INJECTION | 5 |
| 6 | CALCITRIOL | 4 |
| 7 | CALCITRIOL CAPSULES 0.25 MCG | 4 |
| 8 | CALCITRIOL CAPSULES 0.5 MCG | 4 |
| 9 | CALCIUM | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEMIGATINIB | 2 | 0.0023 |
| 1 | BUROSUMAB | 10 | 0.0015 |
| 2 | FERRIC CARBOXYMALTOSE | 5 | 0.0011 |
| 3 | FERRIC DERISOMALTOSE | 1 | 0.0007 |
| 4 | CABAZITAXEL | 1 | 0.0003 |
| 5 | BACITRACIN | 1 | 0.0003 |
| 6 | CYPROHEPTADINE HYDROCHLORIDE | 1 | 0.0002 |
| 7 | ZOLEDRONIC ACID | 9 | 0.0002 |
| 8 | IRON SUCROSE | 2 | 0.0002 |
| 9 | CALCITRIOL CAPSULES 0.25 MCG | 4 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | RANK Ligand Inhibitor [EPC] | 9 |
| 1 | Calcium [EPC] | 4 |
| 2 | Provitamin D2 Compound [EPC] | 4 |
| 3 | Vitamin D3 Analog [EPC] | 4 |
| 4 | Recombinant Human Growth Hormone [EPC] | 3 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 3 |
| 6 | Aminosalicylate [EPC] | 2 |
| 7 | Corticosteroid [EPC] | 2 |
| 8 | Kinase Inhibitor [EPC] | 2 |
| 9 | Microtubule Inhibitor [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vitamin D3 Analog [EPC] | 4 | 0.0002 |
| 1 | Parenteral Iron Replacement [EPC] | 2 | 0.0001 |
| 2 | Recombinant Human Growth Hormone [EPC] | 3 | 0.0001 |
| 3 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 4 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | RANK Ligand Inhibitor [EPC] | 9 | 0.0000 |
| 6 | Calcium [EPC] | 4 | 0.0000 |
| 7 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 8 | Aminosalicylate [EPC] | 2 | 0.0000 |
| 9 | Androgen Receptor Inhibitor [EPC] | 1 | 0.0000 |